Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16800261 | 1.00 | ACACB (0.40) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL25730009 | 0.94 | ACACB (0.39) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL25922603 | 0.92 | ACACB (0.38) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL18328129 | 0.90 | ACACB (0.39) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL20553993 | 0.87 | CHRM2 (0.41) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL20553992 | 0.87 | CHRM2 (0.41) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL38656021 | 0.84 | ACACB (0.38) | ACACBCHRM2CHRM1CHRM3EPHX2 | |
| SCHEMBL25234631 | 0.83 | CHRM2 (0.39) | CHRM2CHRM1CHRM3EPHX2USP2 | |
| SCHEMBL14310674 | 0.81 | CHRM2 (0.37) | CHRM2CHRM1CHRM3EPHX2USP2 | |
| SCHEMBL8936177 | 0.81 | CHRM2 (0.37) | ACACBCHRM2CHRM1CHRM3EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3272747-A1 | METHOD OF PREPARATION FOR LEDIPASVIR AND DERIVATIVE THEREOF, AND INTERMEDIATE COMPOUND FOR PREPARATION OF LEDIPASVIR | Shanghai Forefront Pharmceutical Co., Ltd (CN) | 2018-01-24 | — | — | EP | disclosed |